Here's the clinical trial: https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2019-04957 https://www.cancer.gov/about-cancer/treatmen

Here's the clinical trial: https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2019-04957 https://www.cancer.gov/about-cancer/treatment/clinical-trial... Here's the press release: https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx https://investors.modernatx.com/news/news-details/2022/Moder... Really impressive, as the study is 44% compared with pembrolizumab, which is not bad by itself either! Even more impressive is that it's two big companies working TOGETHER, and have an agreement to split profits!